Radiological characteristics of hepatocellular carcinoma that achieved complete response after chemoembolization with drug-eluting beads for liver transplantation planning

被引:0
|
作者
Valle, Leonardo Guedes Moreira [1 ]
Cunha, Marcela Juliano Silva [1 ]
Schmid, Bruno Pagnin [1 ]
Falsarella, Priscila Mina [1 ]
de Rezende, Marcelo Bruno [1 ]
Felga, Guilherme Eduardo Goncalves [1 ]
Ogawa, Renata Emy [1 ]
Garcia, Rodrigo Gobbo [1 ]
Affonso, Breno Boueri [1 ]
Nasser, Felipe [1 ]
Galastri, Francisco Leonardo [1 ]
机构
[1] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil
来源
EINSTEIN-SAO PAULO | 2023年 / 21卷
关键词
Living donors; Liver neoplasms; Carcinoma; hepatocellular; Chemoembolization; therapeutic; Neoadjuvant therapy; Response evaluation criteria in solid tumors; Radiology; interventional; TRANSARTERIAL CHEMOEMBOLIZATION;
D O I
10.31744/einstein_journal/2023AO0307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To describe the radiological characteristics of hepatocellular carcinoma (HCC) lesions that achieved a complete response following drug-eluting bead transarterial chemoembolization (DEB-TACE) preceding liver transplantation. Methods: This single-center case-control study enrolled patients with hepatocellular carcinoma who underwent neoadjuvant DEB-TACE therapy, were followed up with contrast-enhanced magnetic resonance imaging or computed tomography, and were successively evaluated according to the modified Response Evaluation Criteria in Solid Tumors. The HCCs were divided into two groups based on their diameter (Group A: <= 3cm; Group B: 3cm). Viability was assessed using the Kaplan-Meier method according to tumor size categories. The relationship between tumor variables was analyzed using bivariate Cox regression.Results: Three-hundred and twenty-eight patients with 667 hepatocellular carcinomas who underwent their first DEB-TACE session were enrolled. A total of 105 hepatocellular carcinomas in 59 patients exhibited complete response after the initial DEB-TACE session and were divided into Group A (92 HCCs) and Group B (13 HCCs). The diameter in Group A decreased significantly compared to the pre-procedure size until the second assessment (p<0.001), with no subsequent reduction in diameter, despite maintaining a complete response. In Group B, the reduction in diameter remained significant compared with the initial value until the sixth imaging evaluation (p=0.014). The average reduction was 45.1% for Group B and a maximum of 14.9% in Group A.Conclusion: HCCs >3cm exhibited a greater reduction in size and a longer time to recurrence. HCCs <= 3cm had a shorter relapse time. The recurrence rates were similar. These findings may aid in planning for liver transplantation.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Apparent Diffusion Coefficient as a Noninvasive Biomarker for the Early Response in Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Using Drug-eluting Beads
    Li, Basen
    Zhou, Lei
    Xu, Anhui
    Li, Qin
    Xiang, Huihua
    Huang, Yanrong
    Peng, Ling
    Xiang, Kun
    Zhang, Mingfeng
    Wang, Nan
    CURRENT MEDICAL IMAGING, 2022, 18 (11) : 1186 - 1194
  • [42] Comparison of RECIST, mRECIST, and Choi Criteria for Early Response Evaluation of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Drug-Eluting Beads
    Yeo, Dong Myung
    Choi, Joon-Il
    Lee, Young Joon
    Park, Michael Y.
    Chun, Ho Jong
    Lee, Hae Giu
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2014, 38 (03) : 391 - 397
  • [43] Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads in Hepatocellular Carcinoma: A Single-Center Experience
    Danisan, Gurkan
    Arik, Erbil
    DUZCE MEDICAL JOURNAL, 2022, 24 (02) : 105 - 109
  • [44] Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety
    Zi-shu Zhang
    Hui-zhou Li
    Cong Ma
    Yu-dong Xiao
    BMC Cancer, 19
  • [45] DRUG-ELUTING BEADS VERSUS CONVENTIONAL CHEMOEMBOLIZATION FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA: A META-ANALYSIS
    Facciorusso, A.
    Di Maso, M.
    Muscatiello, N.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E82 - E83
  • [46] Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety
    Zhang, Zi-shu
    Li, Hui-zhou
    Ma, Cong
    Xiao, Yu-dong
    BMC CANCER, 2019, 19 (01)
  • [47] Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion
    Monier, Arnaud
    Guiu, Boris
    Duran, Rafael
    Aho, Serge
    Bize, Pierre
    Deltenre, Pierre
    Dunet, Vincent
    Denys, Alban
    EUROPEAN RADIOLOGY, 2017, 27 (04) : 1431 - 1439
  • [48] Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion
    Arnaud Monier
    Boris Guiu
    Rafael Duran
    Serge Aho
    Pierre Bize
    Pierre Deltenre
    Vincent Dunet
    Alban Denys
    European Radiology, 2017, 27 : 1431 - 1439
  • [49] Early response of treatment to hepatocellular carcinoma using transarterial chemoembolization with drug eluting beads
    Hoang Dong Duc
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 167 - 167
  • [50] Quantification of Functional MR Predicts Early Response in Post-doxorubicin Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma
    Hsin-You Ou
    Yu-Fan Cheng
    Yi-Hsuan Chuang
    Hsien-Wen Hsu
    Chao-Long Chen
    Marirose Zingapan Lazo
    Ching-Chun Weng
    Chun-Yen Yu
    Leo Leung-Chit Tsang
    Tung-Liang Huang
    Yu-Shun Tong
    Digestive Diseases and Sciences, 2020, 65 : 2433 - 2441